HLN

Haleon Stock Analysis

AI Rating

Neutral
  • Quality9/10
  • Growth 0/10
  • Momentum 5/10
Haleon sales and earnings growth
HLN Growth
Low
  • Revenue Y/Y 0.00%
  • EPS Y/Y 0.00%
  • FCF Y/Y 79.91%
Haleon gross and profit margin trends
HLN Profitability
Neutral
  • Gross margin 60.70%
  • EPS margin 12.80%
  • ROIC 20.40%
Haleon recent dividend growth
HLN Dividends
  • Dividend yield 1.08%
  • Growth 3Y 0.00%
  • Payout ratio 51%
Haleon net debt vs free cash flow
HLN Risk
Great
  • Debt / Equity 0.6
  • Debt / FCF 3.9
  • Interest coverage 7.2

Haleon stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗